The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
January 31st 2025
Although there were increases in prescriptions during the studies’ durations, the proportion of anxiety or pain medications on the same day of intrauterine device (IUD) insertion procedures were low.
January 31st 2025
Therapy Shows Early, Encouraging Results in Treating Aggressive Form of Breast Cancer
December 12th 2014Merck's anti"PD-1 therapy Keytruda has demonstrated an overall response rate of 18.5% among patients with PD-L1 positive, advanced triple-negative breast cancer, one of the most aggressive forms of breast cancer.
Read More
PharMEDium Unveils New Tamper Evidence Cap for Pre-Filled Syringes to Enhance Patient Safety
December 11th 2014PharMEDium Services, LLC today announced the launch of MEDGUARDâ„ designed to support patient safety and efficiency throughout the hospital. With MEDGUARD, clinicians will have an unprecedented level of confidence that any syringe medication from PharMEDium will remain unopened and sterile until they choose to break the cap seal.
Read More
New, Personalized Online Community Helps Patients Live With Dangerous Heart Rhythm
December 11th 2014Many people experience a slight quivering or racing heart at some point and usually give it little notice. But for those diagnosed with atrial fibrillation, that irregular heartbeat can be a serious condition that can increase the risk of stroke and needs medical attention.
Read More
APhA Foundation Announces Election Results for its Board of Directors
December 11th 2014The American Pharmacists Association Foundation today announced the election of Troy Trygstad, PharmD, MBA, PhD, re-election of Leonard Edloe, MDiv, PharmD, and appointment of Ed Hamilton, PharmD, FAPhA, to its Board of Directors for the 2015"2018 term. They will be officially installed during the APhA2015 Annual Meeting in San Diego, March 27-30, 2015.
Read More
About Half of Celgene Subjects with Peripheral T-Cell Lymphoma Achieve Complete Response
December 11th 2014Celgene Corporation's study results of romidepsin in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of patients with peripheral T-cell lymphoma showed 51% of patients achieved a complete response, according to a Celgene press release.
Read More